Advanced Malignancy Clinical Trial
Official title:
To Evaluate the Safety, Tolerability, and Initial Efficacy of IBI318 in Patients With Advanced Malignancy, Multicenter, IA/IB Study
An open label, multicenter, phase Ia/Ib study to evaluate the safety, tolerability, and initial efficacy of IBI318 in the treatment of patients with advanced malignancies.
An open label, multicenter, phase Ia/Ib study to evaluate the safety, tolerability, and initial efficacy of IBI318 in the treatment of patients with advanced malignancies. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT00978926 -
A Study of the Pharmacodynamic Effects of Anti-Vascular Endothelial Growth Factor Therapy in Patients With Advanced Malignancies
|
N/A | |
| Completed |
NCT01444404 -
A Study of AMG 820 in Subjects With Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT00428545 -
Bevacizumab and Bortezomib in Patients With Advanced Malignancy
|
Phase 1 | |
| Completed |
NCT02743637 -
A Dose Escalation Study of SDX-7320 in Patients With Advanced Refractory or Late-Stage Solid Tumors
|
Phase 1 | |
| Completed |
NCT01558817 -
Changing the Paradigm of In-Hospital Cardiopulmonary Resuscitation With Informed Assent
|
N/A | |
| Completed |
NCT01253707 -
A Study of AMG 337 in Subjects With Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT01723020 -
A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma
|
Phase 1 | |
| Completed |
NCT00813384 -
A Phase 1 Study of AMG 208 in Subjects With Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT00974896 -
QUILT-2.016: Study of AMG 479 With Biologics or Chemotherapy for Subjects With Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT02110355 -
A Phase 1b/2a Study Evaluating AMG 232 in Metastatic Melanoma
|
Phase 1 | |
| Completed |
NCT02978482 -
A Phase 1/2 Study of Durvalumab(MEDI4736) and Tremelimumab in Chinese Patients With Advanced Malignancies
|
Phase 1 | |
| Completed |
NCT00858377 -
A Phase 1 First-in-Human Study Evaluating AMG 900 in Advanced Solid Tumors
|
Phase 1 | |
| Completed |
NCT04216082 -
A Study of Anlotinib in Subjects With Advanced Malignancy
|
Phase 2 | |
| Terminated |
NCT02437916 -
Safety Study of AMG 228 to Treat Solid Tumors
|
Phase 1 | |
| Terminated |
NCT01231347 -
QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas
|
Phase 3 | |
| No longer available |
NCT01945164 -
XL999 Administered Intravenously to a Subject With Advanced Malignancies
|
N/A | |
| Completed |
NCT02016729 -
A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia
|
Phase 1 |